mitomycin has been researched along with Glaucoma, Neovascular in 25 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Glaucoma, Neovascular: A form of secondary glaucoma which develops as a consequence of another ocular disease and is attributed to the forming of new vessels in the angle of the anterior chamber.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To describe a case of ocular decompression syndrome in a patient after trabeculectomy with mitomycin C for neovascular glaucoma." | 7.70 | Diffuse retinal hemorrhages (ocular decompression syndrome) after trabeculectomy with mitomycin C for neovascular glaucoma. ( Danias, J; Podos, SM; Rosenbaum, J, 2000) |
| " Patients who could not achieve an intraocular pressure ≤21 mm Hg despite medications underwent trabeculectomy with mitomycin C." | 3.76 | Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma. ( Eslami, Y; Fakhraie, G; Katz, LJ; Moghimi, S; Prasad, A; Sabour, S; Zarei, R, 2010) |
| " After trabeculectomy with mitomycin C, mean intraocular pressure was reduced from 42." | 3.76 | Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C. ( Alkawas, AA; Hussein, AM; Shahien, EA, 2010) |
| " The purpose of our study is to assess the efficacy of combining pars plana vitrectomy and PRP with trabeculectomy assisted by mitomycin C (MMC) on NVG eyes secondary to diabetic retinopathy." | 3.73 | Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma. ( Ito, N; Ito, S; Kiuchi, Y; Nakae, K; Saito, Y, 2006) |
| "To determine the outcomes of trabeculectomy with mitomycin C (MMC) combined with direct cauterization of peripheral iris before iridectomy in the management of neovascular glaucoma (NVG), and to demonstrate the effect of this surgical technique on decreasing the incidence of intraoperative bleeding and early postoperative hyphema." | 3.73 | Trabeculectomy with mitomycin C combined with direct cauterization of peripheral iris in the management of neovascular glaucoma. ( Batman, A; Berker, N; Cankaya, B; Elgin, U; Simsek, T, 2006) |
| "To assess the efficacy and to determine the risk factors of trabeculectomy with mitomycin C (MMC) in eyes with neovascular glaucoma (NVG) secondary to diabetic retinopathy." | 3.73 | Trabeculectomy with mitomycin C for treatment of neovascular glaucoma in diabetic patients. ( Ito, S; Kiuchi, Y; Nakae, K; Saito, Y; Sugimoto, R, 2006) |
| "To describe a case of ocular decompression syndrome in a patient after trabeculectomy with mitomycin C for neovascular glaucoma." | 3.70 | Diffuse retinal hemorrhages (ocular decompression syndrome) after trabeculectomy with mitomycin C for neovascular glaucoma. ( Danias, J; Podos, SM; Rosenbaum, J, 2000) |
| "Multiple sclerosis is associated with iridocyclitis, intermediate uveitis, retinal periphlebitis, and optic neuritis." | 1.37 | Bilateral rubeosis iridis and rubeotic glaucoma due to peripheral occlusive vasculitis associated with multiple sclerosis. ( Deane, J; Dharmasena, A; Turner, SJ, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 13 (52.00) | 29.6817 |
| 2010's | 10 (40.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, X | 1 |
| Wang, Y | 1 |
| Yang, L | 1 |
| Wang, P | 1 |
| Chen, K | 1 |
| Zhou, L | 1 |
| Wu, Y | 1 |
| Dong, Z | 1 |
| Gong, J | 1 |
| Liao, R | 1 |
| Xu, S | 1 |
| Babiker, S | 1 |
| Elsayed, ME | 1 |
| Dhaygude, A | 1 |
| Madgula, I | 1 |
| Anand, N | 1 |
| Bong, C | 1 |
| Elmekawey, H | 1 |
| Khafagy, A | 1 |
| Kobayashi, S | 1 |
| Inoue, M | 1 |
| Yamane, S | 1 |
| Sakamaki, K | 1 |
| Arakawa, A | 1 |
| Kadonosono, K | 1 |
| Caça, I | 1 |
| Ari, S | 1 |
| Sakalar, YB | 1 |
| Unlü, K | 1 |
| Dogan, E | 1 |
| Takihara, Y | 2 |
| Inatani, M | 2 |
| Fukushima, M | 2 |
| Iwao, K | 2 |
| Iwao, M | 2 |
| Tanihara, H | 2 |
| Fakhraie, G | 1 |
| Katz, LJ | 1 |
| Prasad, A | 1 |
| Eslami, Y | 1 |
| Sabour, S | 1 |
| Zarei, R | 1 |
| Moghimi, S | 1 |
| Saito, Y | 3 |
| Higashide, T | 1 |
| Takeda, H | 1 |
| Ohkubo, S | 1 |
| Sugiyama, K | 1 |
| Alkawas, AA | 1 |
| Shahien, EA | 1 |
| Hussein, AM | 1 |
| Kawaji, T | 1 |
| Turner, SJ | 1 |
| Dharmasena, A | 1 |
| Deane, J | 1 |
| Mandal, AK | 1 |
| Majji, AB | 1 |
| Mandal, SP | 1 |
| Das, T | 1 |
| Jalali, S | 1 |
| Gothwal, VK | 1 |
| Jain, SS | 1 |
| Nutheti, R | 1 |
| Jordan, JF | 1 |
| Parmar, P | 1 |
| Salman, A | 1 |
| Euswas, A | 1 |
| Warrasak, S | 1 |
| Kiuchi, Y | 2 |
| Nakae, K | 2 |
| Ito, S | 2 |
| Ito, N | 1 |
| Elgin, U | 1 |
| Berker, N | 1 |
| Batman, A | 1 |
| Simsek, T | 1 |
| Cankaya, B | 1 |
| Sugimoto, R | 1 |
| Arikan, G | 1 |
| Saatci, AO | 1 |
| Soylev, MF | 1 |
| Kocak, N | 1 |
| Sisto, D | 1 |
| Vetrugno, M | 1 |
| Trabucco, T | 1 |
| Cantatore, F | 1 |
| Ruggeri, G | 1 |
| Sborgia, C | 1 |
| Olivier, MM | 1 |
| Kupin, TH | 1 |
| McDermott, ML | 1 |
| Shin, DH | 1 |
| Danias, J | 1 |
| Rosenbaum, J | 1 |
| Podos, SM | 1 |
| Hyung, SM | 1 |
| Kim, SK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular[NCT04970251] | 5 participants (Actual) | Interventional | 2018-11-01 | Completed | |||
| Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma[NCT01922154] | Phase 4 | 15 participants (Actual) | Interventional | 2009-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for mitomycin and Glaucoma, Neovascular
| Article | Year |
|---|---|
Effectiveness of multiple therapeutic strategies in neovascular glaucoma patients: A PRISMA-compliant network meta-analysis.
Topics: Angiogenesis Inhibitors; Anti-Infective Agents; Bevacizumab; Combined Modality Therapy; Glaucoma, Ne | 2018 |
[Modulation of wound healing in filtration surgery for glaucoma].
Topics: Adolescent; Adult; Age Factors; Alkylating Agents; Animals; Antimetabolites; Child; Filtering Surger | 2003 |
2 trials available for mitomycin and Glaucoma, Neovascular
| Article | Year |
|---|---|
Comparison of conbercept and ranibizumab combined mitomycin C-augmented trabeculectomy for neovascular glaucoma.
Topics: Angiogenesis Inhibitors; Glaucoma, Neovascular; Humans; Intraocular Pressure; Intravitreal Injection | 2021 |
The role of antimetabolites in filtration surgery for neovascular glaucoma: intermediate-term follow-up.
Topics: Adult; Aged; Antimetabolites; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Gl | 2007 |
21 other studies available for mitomycin and Glaucoma, Neovascular
| Article | Year |
|---|---|
A complex case of haemodialysis induced increased intraocular pressure.
Topics: Acetazolamide; Antihypertensive Agents; Diabetes Mellitus, Type 1; Glaucoma, Neovascular; Humans; In | 2019 |
Deep sclerectomy with bevacizumab and mitomycin C: a comparative study.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Ca | 2015 |
Intracameral ranibizumab and subsequent mitomycin C augmented trabeculectomy in neovascular glaucoma.
Topics: Alkylating Agents; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Combined Modality The | 2014 |
Long-term Outcomes After Preoperative Intravitreal Injection of Bevacizumab Before Trabeculectomy for Neovascular Glaucoma.
Topics: Adult; Aged; Alkylating Agents; Angiogenesis Inhibitors; Bevacizumab; Female; Follow-Up Studies; Gla | 2016 |
Trabeculectomy with mitomycin-C in neovascular galucoma patients.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Female; Glaucoma, Neovascular; Humans; Intraocul | 2008 |
Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; F | 2009 |
Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bev | 2010 |
Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma.
Topics: Aged; Anterior Chamber; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Chor | 2010 |
Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
Topics: Adult; Aged; Alkylating Agents; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclo | 2010 |
Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Angiogenesis Inhibitors; Antibodies, Monoclonal; | 2011 |
Bilateral rubeosis iridis and rubeotic glaucoma due to peripheral occlusive vasculitis associated with multiple sclerosis.
Topics: Acetazolamide; Adult; Glaucoma, Neovascular; Humans; Immunosuppressive Agents; Iritis; Light Coagula | 2011 |
Mitomycin-C-augmented trabeculectomy for neovascular glaucoma. A preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Female; Glaucoma, Neovascular; Humans; | 2002 |
Mitomycin-C-augmented trabeculectomy for neovascular glaucoma. A preliminary report.
Topics: Glaucoma, Neovascular; Humans; Mitomycin; Trabeculectomy | 2003 |
Long-term results of early trabeculectomy with mitomycin-C and subsequent posterior segment intervention in the treatment of neovascular glaucoma with hazy ocular media.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Female; Glaucoma, Neovascular; Humans; | 2005 |
Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma.
Topics: Adult; Aged; Alkylating Agents; Combined Modality Therapy; Diabetic Retinopathy; Glaucoma, Neovascul | 2006 |
Trabeculectomy with mitomycin C combined with direct cauterization of peripheral iris in the management of neovascular glaucoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Cautery; Combined Modality Therapy; Female; Glaucoma, Neov | 2006 |
Trabeculectomy with mitomycin C for treatment of neovascular glaucoma in diabetic patients.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Cryotherapy; Diabetic Retinopathy; Female | 2006 |
Bilateral combined cilioretinal artery and central retinal vein occlusion.
Topics: Arterial Occlusive Diseases; Ciliary Arteries; Diabetes Mellitus, Type 2; Fundus Oculi; Glaucoma, Ne | 2006 |
Intracameral tissue plasminogen activator in neovascular glaucoma.
Topics: Adult; Female; Glaucoma, Neovascular; Humans; Intraocular Pressure; Mitomycin; Thrombosis; Tissue Pl | 1993 |
Diffuse retinal hemorrhages (ocular decompression syndrome) after trabeculectomy with mitomycin C for neovascular glaucoma.
Topics: Aged; Antimetabolites; Glaucoma, Neovascular; Humans; Intraocular Pressure; Male; Mitomycin; Retinal | 2000 |
Mid-term effects of trabeculectomy with mitomycin C in neovascular glaucoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Female; Glaucoma, Neovascular; Humans; | 2001 |